Pediatric Cardiomyopathy Mutation Analysis

ConditionsCardiomyopathies Dilated Cardiomyopathy Hypertrophic Cardiomyopathy Restrictive Cardiomyopathy Arrhythmogenic Right Ventricular Cardiomyopathy Left Ventricular Non-compaction Cardiomyopathy

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorIndiana University

About this trial

The goal of this protocol is to obtain information from individuals with cardiomyopathy and from their families in order to elucidate the molecular genetics of this disorder. This will provide the basis for future genetic counseling as well as contribute to elucidating the biology of normal and abnormal cardiac function.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Subjects with cardiomyopathy

Family members of subjects with cardiomyopathy

Disqualifiers

Subjects without cardiomyopathy

Family members of subjects without cardiomyopathy

Trial population

Families affected by cardiomyopathy

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

300 Participants

are grouped into 2 trial groups

Group A: Affected

Group B: Family Members of affected

Trial outcomes

Primary outcomes

Elucidate the molecular genetics of cardiomyopathy

Time frame

7 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Indiana University

Lead sponsor

American Heart Association

Collaborator

Source ClinicalTrials.gov

Apply now